Skip to main content

Advertisement

SpringerLink
Log in

Vasculitis

Benralizumab noninferior to mepolizumab for EGPA

  • Research Highlight
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

Related article

  • Emmi, G. et al. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat. Rev. Rheumatol. 19, 378–393 (2023)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Rheumatology http://www.nature.com/nrrheum/

    Sarah Onuora

Authors
  1. Sarah Onuora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Onuora.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onuora, S. Benralizumab noninferior to mepolizumab for EGPA. Nat Rev Rheumatol 20, 253 (2024). https://doi.org/10.1038/s41584-024-01116-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-024-01116-6

  • Springer Nature Limited

Search

Navigation